Answer
Yes, daunorubicin hydrochloride can cause mouth inflammation (mucositis/stomatitis), generally early after administration, which, if severe, may progress within a few days to mucosal ulcers; most patients recover by the third week of therapy.
Sources for this answer
- Daunorubicin 20mg Powder for InjectionZentiva · emc · SmPC §4.4 Special warnings and precautions for use · Version 7Document updated
Sources checked